At the news
? NEUTRALIMPACT 1/10 PRESS-RELEASE filed May 1, 2026 at 08:00 ET
Phathom Pharmaceuticals announced its participation in the Digestive Disease Week (DDW) 2026 annual meeting, including a product theater presentation for VOQUEZNA and three poster presentations. This is a routine conference attendance with no material financial or regulatory impact.
- Phathom will participate in DDW 2026 (May 2-5, Chicago) with a product theater presentation on VOQUEZNA on May 4.
- The company will present three posters covering clinical, patient-reported, and real-world data for VOQUEZNA in GERD.
- Poster abstracts will be available on the company website after the meeting.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access